Previous Article | Next Article ![]()
Journal of Virology, November 2006, p. 10734-10742, Vol. 80, No. 21
0022-538X/06/$08.00+0 doi:10.1128/JVI.00349-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathumthani 12120, Thailand,1 Centex Shrimp, Faculty of Science, Mahidol University, Rama VI Rd., Bangkok 10400, Thailand,2 Institute of Zoology, National Taiwan University, Taipei, Taiwan, Republic of China3
Received 23 February 2006/ Accepted 31 July 2006
|
|
|---|
|
|
|---|
All three of the WSSV isolates that have been sequenced have a genome of about 300 kbp, and genetic comparisons have shown a high degree of genetic similarity (16). The availability of the complete WSSV sequence facilitates the global molecular characterization of the virus by genomic and proteomic approaches and has recently led to the discovery of many important WSSV genes, including latency-associated genes (10, 11), immediate-early genes (15), many other nonstructural genes (5, 29, 30, 33), and more than 39 structural genes (6, 13, 19, 31, 32, 35, 43). To date, however, little is known of the interaction between shrimp and WSSV at the cellular and molecular levels.
Neutralization experiments with a major WSSV envelope protein, VP28, have shown that it is involved in systemic infection of WSSV (34). It has further been shown that VP28 is able to bind to the surface of shrimp cells (41) and that feeding with recombinant VP28 can protect shrimp from WSSV infection (38). However, until now there have been no reports on the interaction of VP28 with a specific shrimp protein(s). Therefore, in the present study, to identify shrimp hemocyte membrane (SHM) proteins involved in WSSV binding, a virus overlay protein binding assay (VOPBA) was performed (9, 21). VP28 was selected as the WSSV target because it is the most abundant exposed protein in the WSSV envelope (32). One of the candidate proteins from this assay was further characterized, and its full-length sequence was analyzed. Its expression pattern in response to WSSV infection was investigated, and a glutathione S-transferase (GST) pull-down assay tested the specificity of its binding to recombinant VP28 (rVP28). An enzyme-linked immunosorbent assay (ELISA) and an in vivo neutralization assay were also conducted. This is the first study to describe the specific binding of a shrimp protein to the WSSV major structural protein VP28.
|
|
|---|
Expression and purification of recombinant WSSV VP28 protein. The WSSV VP28 gene was PCR amplified from WSSV genomic DNA by using the forward primer 5'-GGA TCT AAG CTTA (CAT)6 ATA ATG GAT CTT TCT TT-3' and the reverse primer 5'-CAA TGA GCT CTT ACT CGG TCT CAG TG-3'. The forward primer contained recognition sequences for HindIII with a His6 tag, and the reverse primer had a recognition site for SacI. For the template, DNA was extracted from a WSSV-infected shrimp that had been diagnosed using a commercial WSSV detection kit (IQ2000 WSSV detection kit; Farming Intelligene Co., Ltd., Taiwan). The PCR amplicon was cloned into pET-17b vector (Novagen). The recombinant plasmid was transformed into Escherichia coli strain BL21, and the insert was confirmed by sequencing. The fusion recombinant protein (i.e., as rVP28) was purified by Ni-nitrilotriacetic acid-ribotriacetic acid affinity chromatography according to the manufacturer's protocol (QIAGEN). The purified rVP28 was stored at 20°C.
Preparation of shrimp hemocyte membrane protein. Hemolymph from adult specific-pathogen-free shrimp was collected in AC-1 anticoagulant solution (27) at a hemolymph/AC-1 ratio of 1:2. The hemocyte pellet was collected, resuspended, and homogenized in 0.9% NaCl. This lysate was then sedimented by centrifugation, and the supernatant portion was collected and ultracentrifuged at 100,000 x g for 1 h at 4°C. After ultracentrifugation, the pellet was solubilized in NaCl/phosphate buffer (7) with 1% Triton X-100, 1x protease inhibitor mix (Amersham Biosciences). The suspension was ultracentrifuged, and the supernatant was collected and referred to as shrimp hemocyte membrane protein solution. The total protein concentration in SHM protein solution was determined using Bradford's reagent protein assay (Bio-Rad). To determine the membrane protein profile, the SHM fraction was subjected to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie brilliant blue.
Western blot analysis of rVP28. Purified rVP28 was separated by standard SDS-PAGE (12). For immunoblotting experiments, the purified rVP28 was electrophoresed and transferred to a nitrocellulose membrane (Amersham Biosciences). The membrane was immersed in blocking buffer (5% skim milk in 140 mM phosphate-buffered saline [PBS]) before incubation overnight at 4°C with a 1:1,000 dilution of mouse anti-VP28 antiserum (kindly provided by P. Sithikornkul, Srinakarinwirote University, Bangkok, Thailand). The blot was then washed twice and incubated for 2 h with a 1:2,000 dilution of goat anti-mouse immunoglobulin G conjugated with horseradish peroxidase (HRP) (Zymed). Subsequently, the blot was washed extensively and the color was developed with an AEC (red) substrate kit (Zymed).
Determination of WBPs by VOPBA. To identify hemocyte membrane proteins involved in WSSV binding, a VOPBA was carried out (9, 21). SHM (50 µg) was separated by 12% SDS-PAGE and then transferred to a nitrocellulose membrane. Prior to the binding assay, the membrane was incubated with 5% skim milk in PBS buffer for 1 h. Following two washes, the membrane was equilibrated for 20 min with binding buffer (10 mM Tris-HCl [pH 6.5], 5 mM CaCl2, 10 mM MgCl2). Subsequently, the membrane was incubated with 0.8 mg of affinity-purified rVP28 (dialyzed against binding buffer at 4°C for 48 h) diluted in binding buffer with 0.02% skim milk and 1% Triton X-100. The membrane was extensively washed and WSSV-rVP28-binding proteins (WBPs) were detected by incubating with diluted mouse anti-VP28 antiserum (1:1,500). After washing, the blot was incubated with rabbit anti-mouse IgG-conjugated HRP (Roche). The hemocyte membrane proteins that interacted with rVP28 were detected by the addition of HRP substrate (0.003% [wt/vol] 3',3'-diamino-benzenetetrahydrochloride [Sigma]-0.05% [wt/vol] H2O2).
Mass spectrometry analysis. For internal sequence analysis, the WBPs were excised from the 12% SDS-polyacrylamide gel and separately digested overnight in gel with trypsin at 37°C. Liquid chromatography-electrospray ionization tandem mass spectrometry was performed, and the MASCOT program was used to analyze the results as described by Tsai et al. (31).
Expression of recombinant PmRab7.
The
nucleotide sequence of shrimp Rab7 cDNA was identified
from the information in a Taiwan expressed sequence tag
library constructed from whole postlarval shrimp (C. F. Lo,
unpublished data). The P. monodon Rab7 (PmRab7) sequence was
analyzed and aligned with those of other Rab proteins from other
microorganisms with BLAST 2.0
(http://www.ncbi.nlm.nih.gov/BLAST/)
and Clustal W 1.7 multiple sequence alignment
(http://www.ebi.ac.uk/clustalw/).
Primers were designed to clone full-length PmRab7 in frame with both
pET17b (Novagen) and pGEX4T-1 vector (Amersham Biosciences) for the
production of recombinant PmRab7 fused with a His tag at its N terminus
and GST at its C terminus, respectively. For pET17b vector, the forward
primer 5'-CGA CGA TAG GTA CCC ATG GCA TCT TCG AA-3' and
the reverse primer 5'-TCG AGA CTC GAG GTG ATG GTG ATG GTG ATG
TTA GCA AGA GCA TG-3' were used. For GST fusion, the PmRab7
forward primer 5'-CGA CGA GAT GAA TTC ATG GCA TCT CGC AAG
AA-3' and the PmRab7 reverse primer 5'-CTA CTA GAG CGG
CCG CGC AAG AGC ATG CAT-3' were used. The protein was expressed
in E. coli strain BL21 for the pET17b vector (as described
above), whereas the protein with the GST tag was expressed in bacterial
strain DH5
(Novagen). Protein production was accomplished by
standard methods for bacterial growth, followed by induction with IPTG
(isopropyl-ß-D-thiogalactopyranoside). The
His6-PmRab7 (rPmRab7) was used in ELISA and in vivo
neutralization tests (K. Sritunyalucksana et al., 25 August 2006, Thai
patent applications 0601004059 and 0601004060), whereas the GST-PmRab7
was used in GST pull-down assays. The rPmRab7 amino acid sequence was
confirmed by liquid chromatography-electrospray ionization tandem mass
spectrometry as described above. The specific binding of anti-Rab7
antibody to rPmRab7, as well as to Rab7 in SHM, was tested by Western
blot analysis.
GST pull-down assay. The GST fusion protein was purified using glutathione-Sepharose 4B resin (Amersham Biosciences). For the pull-down experiment, the interaction between rVP28 and GST-PmRab7 was examined by incubating purified GST-PmRab7 (1 µg) with a glutathione-Sepharose 4B resin (50 µl of a 50% bed slurry) for 1 h. Purified rVP28 was added, and incubation was continued for another 2 h at room temperature. Control reactions with GST plus rVP28, GST-PmRab7 plus bovine serum albumin (BSA), and GST-PmRab7 alone were included in the assay. After incubation, the beads were washed 10 times with PBS, pH 7.5. Fusion proteins were eluted by the addition of buffer containing reduced glutathione. The proteins were resolved by 12% SDS-PAGE and transferred onto nitrocellulose membranes. Blots were incubated with antihistidine antibody conjugated with HRP (Amersham Biosciences) and visualized using HRP substrate, as described above. To confirm the presence of GST-PmRab7, the blots were tested with anti-GST antibody conjugated with HRP (Amersham Biosciences).
Analysis of expression of the PmRab7 transcript. Total RNAs were extracted from different organs (gill tissue, lymphoid tissue, hepatopancreas, stomach, heart, and hemocyte) of penaeid shrimp (WSSV-free P. monodon) by using TRIzol reagent (Invitrogen) according to the manufacturer's protocol. Reverse transcriptase PCRs (RT-PCRs) were carried out using the SuperScript III one-step RT-PCR kit (Invitrogen). The primer set used was the same as for GST-PmRab7 plasmid construction. The reactions were performed with the annealing temperature at 55°C. The amplified products were analyzed by electrophoresis on a 1.2% agarose gel.
For quantitation of WSSV, a TaqMan probe for WSSV detection was 6-carboxyfluorescein-5'-CGC TTC AGC CAT GCC AGC CG-3'-6-carboxytetramethylrhodamine. The primers were WSSV1 (5'-CCG ACG CCA AGG GAA CT-3') and WSSV2 (5'-TTC AGA TTC GTT ACC GTT TCC A-3'). The TaqMan real-time PCR assay was carried out using TaqMan Universal PCR Master Mix (PE Applied Biosystems). A standard curve for WSSV was constructed as previously described (28). Quantitation of WSSV amplicons was accomplished by measuring the cycle threshold (CT) value. Since the plot of log of initial target copy number for the TaqMan assay was identical to that in WSSV DNA, it was considered that CT values obtained with infected shrimp DNA extracts could be converted to the numbers of viral genomic DNA targets by using the standard curve, and they are referred to here as viral titers. Relative amounts of PmRab7 expression were calculated from the CT value of PmRab7 divided by CT value of 18S rRNA.
WSSV purification. The virus used in this study was isolated from WSSV-infected P. monodon shrimp from Thailand. WSSV purification followed the method described by Wang et al. (37). The viral titer (108 copies/µl) was determined by real-time PCR as described above. Viral preparations were stored at 20°C. The purity of the WSSV preparation was determined by transmission electron microscopy.
Determination of binding specificity by ELISA. Flat-bottomed 96-well ELISA plates (Nunc) were coated with 100 µg of either SHM, purified His6-PmRab7, or BSA (100 µg). The plates were incubated in a humid chamber at 4°C overnight and then blocked with 150 µl of 10% heat-inactivated fetal bovine serum (HyClone) diluted in PBS buffer for 2 h at room temperature. The plates were washed with PBS buffer containing 0.05% Tween 20, and various dilutions of rVP28 (0 to 200 µg) or WSSV titer (10 to 108 copies) were added. After incubation at room temperature for 1 h followed by extensive washing, mouse anti-VP28 antibody was added and the bound anti-VP28 antibody was detected with a 1:2,000 dilution of HRP-labeled goat anti-mouse antibody (Dako). The reaction was visualized using the HRP substrate 3,3,5,5'-tetramethylbenzidine (Sigma). The reaction was stopped by the addition of 2 N H2SO4, and the absorbance was immediately read at 450 nm using an ELISA reader (VersaMax).
For blocking the ELISA, coated plates were first blocked with various dilutions (from undiluted to 1:1,024) of rabbit anti-Rab7 antibody (anti-Rab7) (rabbit polyclonal IgG raised against epitopes corresponding to amino acids 158 to 207 of Rab7 of human origin [Santa Cruz]) or anti-shrimp molt-inhibiting hormone antibody (anti-MIH) (kindly provided by P. Wongthai and B. Withyachumnarnkul, Mahidol University, Thailand). This was followed by washing, reaction with 100 µg of rVP28 or 1,000 copies of WSSV, and detection of bound rVP28 or WSSV by anti-VP28 antibody as described above.
In vivo neutralization. Penaeus vannamei shrimp (6 to 8 g [fresh weight]) were divided into five groups, with three replicates of 10 shrimp in each group. One replicate of each group was used to collect shrimp at intervals for histological examination. Shrimp were injected as follows: group 1 with WSSV (103 copies/shrimp) (positive control), group 2 with TN buffer (20 mM Tris-HCl, 400 mM NaCl [pH 7.4]) (buffer negative control), group 3 with WSSV plus PmRab7 (10 µg/shrimp) as the recombinant protein test, group 4 with WSSV plus anti-Rab7 antibody (diluted 1:10 in TN buffer) as the anti-Rab7 test, and group 5 with WSSV plus anti-MIH (diluted 1:50 in TN buffer) as the antibody negative control. The antibody or PmRab7-plus-WSSV preparations were mixed and immediately injected into the experimental shrimp. The experiment was carried out twice using the semipurified WSSV described above. Cumulative mortality at 13 days after WSSV injection was recorded and compared by one-way analysis of variance using Sigmastat software (Jandel Scientific Co., Ltd.). Differences were considered significant when the P value was <0.05.
Histological examination. On day 4 postchallenge with WSSV, all shrimp survivors were sacrificed by stunning in ice water and fixed with Davidson's fixative, and cephalothoraxes were processed by standard methods (14) for histological detection of pathognomonic lesions of WSSV (14).
Nucleotide sequence accession number. The full-length sequence of Rab7 in the shrimp P. monodon has been deposited in GenBank under accession number DQ231062.
|
|
|---|
![]() View larger version (95K): [in a new window] |
FIG. 1. SDS-PAGE
profile of recombinant WSSV envelope protein VP28 production. Lane 1,
noninduced bacterial cell lysate; lane 2, induced bacterial cell
lysate; lane 3, rVP28 purified by use of a Ni-nitrilotriacetic
acid-ribotriacetic acid affinity chromatography column; lane 4, rVP28
detected with anti-VP28 antibody. The arrow shows a 29-kDa rVP28. Lane
M, protein molecular mass
markers.
|
![]() View larger version (77K): [in a new window] |
FIG. 2. Results
from VOPBA show the binding of rVP28 to SHM protein solution. Lane 1,
Coomassie blue staining of shrimp hemocyte membrane protein; lane 2,
blot of SHM incubated with rVP28 and then probed with anti-VP28
antibody reveals three rVP28-reactive bands; lane 3, blot of rVP28 (29
kDa) probed with anti-VP28 antibody. Lane M, protein molecular mass
markers.
|
|
View this table: [in a new window] |
TABLE 1. Analysis
of WBPs by LC-MS/MS and MASCOT
program
|
25 kDa), suggesting that PmRab7 may undergo
posttranslational modification. Consistent with this, Fig.
3B shows that the C
terminus has two cysteine residues that may be isoprenylated, a crucial
posttranslational modification that enables Rab proteins to associate
and target the cell membrane
(4). More importantly,
PmRab7 has the four conserved GTP-binding or GTPase regions of the
small G protein superfamily (G1 and G3 to G5), as well as an effector
site (G2). These five regions are characteristic of Rab proteins
(1). The sequence analysis
suggests that PmRab7 may be an active GTPase that could cycle between
the GDP- and GTP-bound states. PmRab7 is the first Rab homologue from
crustaceans to be identified and characterized.
![]() View larger version (57K): [in a new window] |
FIG. 3. Primary
structure of PmRab7 and sequence comparison. (A) Primary
structure of PmRab7 cDNA and deduced amino acid sequence. The long
3' untranslated sequence is included, and the polyadenylation
signal is underlined. The start codon and the initiation methionine are
in boldface. The stop codon is shown by an asterisk. The three matched
peptide sequences from the MASCOT search are boxed. Ion scores for
these three sequences were 52, 40, and 46, respectively. (B)
Comparison of Rab7 amino acid sequences from different organisms. The
putative PmRab7 (accession no. DQ231062) is
shown aligned with sea anemone Rab7 (Aiptasia pulchella;
AAQ23388), mouse Rab7 (Mus musculus; CAJ18560.1), human Rab7
(Homo sapiens; AAA86640), rat Rab7 (Rattus
norvegicus; NP_076440), dog Rab7 (Canis
familiaris; NP_001003316), rabbit Rab7 (Oryctolagus
cuniculus; AAD02564), and zebrafish Rab7 (Danio rerio;
AAH54602). Identical amino acids found in all sequences are indicated
by asterisks; gaps were introduced to allow the best alignment. The
putative effector binding domain (G2) is underlined. Conserved domains
G1 and G3 to G5 are indicated by shaded boxes. Potential isoprenylation
sites are indicated
(#).
|
|
View larger version (24K): [in a new window] |
FIG. 4. Tissue
expression of PmRab7. The transcript of PmRab7 (617-bp product) was
detected by RT-PCR in different tissues. Hp, hepatopancreas; Hc,
hemocytes; Lo, lymphoid organ; Sm, stomach; G, gill; Ht,
heart.
|
![]() View larger version (47K): [in a new window] |
FIG. 5. Results
from GST pull-down assays show the specific binding of rVP28 to PmRab7.
(A) Coomassie brilliant blue staining; (B)
immunoblotting using antihistidine antibody; (C)
immunoblotting using anti-GST antibody. Reaction components for each
Sepharose 4B resin are shown at the bottom of each lane.Recombinant VP28 was coprecipitated with GST-Rab7 (lanes 2 and 6). Lane
M, protein molecular mass
markers.
|
![]() View larger version (20K): [in a new window] |
FIG. 6. Binding
of rVP28 or WSSV particles to purified PmRab7. Purified rPmRab7 (100
µg) or SHM (100 µg) was applied to a microwell plate
incubated with different amounts of rVP28 (0 to 200 µg)
(A) or purified WSSV (viral titer of 10 to 108
copies) (B). A test with coated BSA was also performed as negative
control. The binding specificity was determined with anti-VP28 antibody
and secondary antibody conjugated with HRP. Error bars indicate
standard
deviations.
|
![]() View larger version (56K): [in a new window] |
FIG. 7. Protein
profile of rPmRab7 production. Lane 1, noninduced bacterial cell
lysate; lane 2, induced bacterial cell lysate; lane 3,
affinity-purified rPmRab7; lane 4, rPmRab7 probed with anti-Rab7
antibody (rPmRab7 is shown by the solid arrow); lane 5, Rab7 in shrimp
hemocyte membrane probed with anti-Rab7 antibody (membrane PmRab7 is
shown by the dotted arrow). Lane M, protein molecular mass
markers.
|
![]() View larger version (20K): [in a new window] |
FIG. 8. Anti-Rab7
antibody inhibits the binding of rVP28 or WSSV to PmRab7. SHM or PmRab7
(100 µg) was applied to a microwell plate and incubated with
different dilutions of anti-Rab7 antibody or anti-MIH antibody
(positive control). After removal of excess antibodies, rVP28 (100
µg) (A) or purified WSSV (103 copies)
(B) was added to each well. The amount of rVP28 or
WSSV binding to PmRab7 were determined with
anti-VP28 antibody and secondary antibody conjugated with HRP. The
binding was determined by spectrophotometry after addition of HRP
substrate (ELISA score). Only one replicate was done for SHM plus
anti-MIH and PmRab7 plus anti-MIH. Error bars indicate standard
deviations.
|
![]() View larger version (21K): [in a new window] |
FIG. 9. Neutralization
of WSSV with anti-Rab7 antibody and PmRab7. On day
0, shrimp were injected as follows: group 1, WSSV (103
copies/shrimp); group 2, TN buffer; group 3, WSSV plus PmRab7 (10
µg/shrimp); group 4, WSSV plus anti-Rab7 antibody; group 5,
WSSV plus anti-MIH antibody. Cumulative mortality data represent the
pooled results for two replications (n = 10 for each
group). The experiment was done two times. Error bars indicate standard
deviations.
|
![]() View larger version (165K): [in a new window] |
FIG. 10. Histological
examination (magnification, x400) of experimental shrimp on day
4 postchallenge. (A) Shrimp injected with WSSV (group 1);
(B) shrimp injected with WSSV plus anti-Rab7 antibody (group
4); (C) shrimp injected with WSSV plus PmRab7 (group 3);
(D) shrimp injected with buffer (group
2).
|
|
|
|---|
It is well known that many viruses use endocytosis as a route of entry into host cells (23, 25, 26). According to this model, a virus binds to cell surface receptors and is then internalized into the endocytic network in a manner that is generally considered to be calthrin dependent. For example, adenovirus subgroup B (Ad7) undergoes high-affinity interaction with its receptor Ad7 that is colocalized with Rab7 as it is trafficked to late endosomes (18). Rabs act as molecular switches to control trafficking of endocytic vesicles within cells, as well as their subsequent fusion to endosomes However, our work now shows that an enveloped virus can bind directly to a Rab protein (Fig. 2, 5, 6, 8, and 9). In particular, Fig. 6 shows that PmRab7 binds to WSSV virions and to the recombinant WSSV envelope protein or VP28 in a dose-dependent manner, Fig. 8 shows that anti-Rab7 antibody can inhibit these interactions, and Fig. 5 confirms the specificity of this binding. Further tests, such as immunofluorescence by confocal microscopy or immunogold labeling for transmission electron microscopy, would be necessary to establish whether or not PmRab7 is localized at the hemocyte cell surface. If it is, then simple receptor interference would explain the protective effect of PmRab7 and anti-PmRab7 in our WSSV challenge tests (see below). If, on the other hand, it is exclusively localized in cytoplasmic membranes as previously suggested (1), the mechanism for this protection would be more complex. For example, prior binding of PmRab7 to WSSV via VP28 might interfere with viral binding to the cell surface via a different receptor, but an explanation for protection by anti-PmRab7 would be more difficult. Thus, we believe that the balance of our results leans in favor of at least some presence of PmRab7 at the cell surface, despite previous information suggesting that it is exclusively cytoplasmic (1).
In vivo neutralization experiments have been widely used for many vertebrate viruses and have led to the development of passive immunization strategies. In shrimp, use of an anti-VP28 antibody resulted in a low cumulative mortality in immersion or challenge tests with WSSV (34). Witteveldt et al. (38) also showed that injection of recombinant VP28 could reduce the mortality caused by WSSV in shrimp. Similarly, a reduction and delay in mortality were observed upon the use of antibodies to other WSSV envelope proteins, such as VP68, VP281, and VP466 (40). Using an alternative strategy for the first time in shrimp, we have shown that either PmRab7 or an antibody to it can reduce and delay mortality upon WSSV challenge. These results may open the way for the design of novel methods to prevent shrimp death from WSSV infection.
This investigation was supported financially by National Center for Genetic Engineering and Biotechnology (BIOTEC) grant BT-B-07-SG-B7-4512 and by a National Research Council of Thailand grant.
|
|
|---|
subunit demonstrated by virus overlay protein binding assay.J. Gen. Virol.
77:2437-2440.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»